Skip to main content

Table 2 Regression analyses of predictor variables for sustained viremia trajectory (>80 copies/mL or lower limit)

From: Trajectory analyses of virologic outcomes reflecting community-based HIV treatment in Washington DC 1994–2012

 

Univariate analysis

Multivariate analysis

Variables

P value

OR (95 % CI)

P value

OR (95 % CI)

Agea

0 · 506

1 · 0069 (0 · 9865–1 · 0276)

0 · 0114

1 · 0316 (1 · 0078–1 · 0559)

Education

0 · 006

0 · 5309 (0 · 3360–0 · 8388)

0 · 0309

0 · 586 (0 · 3591–0 · 9562)

Race

0 · 0001

--

--

--

African American

0 · 0082

2 · 1658 (1 · 2214–3 · 8404)

0 · 0153

2 · 1852 (1 · 162–4 · 1093)

Hispanic ethnicity

0 · 0799

0 · 446 (1 · 807–1 · 1011)

0 · 321

0 · 6088 (0 · 2284–1 · 6222)

Other ethnicity

0 · 7244

1 · 2547 (0 · 3554–4 · 4292)

0 · 4003

1 · 7358

(0 · 4802–6 · 274)

    

CD4/100a

<0 · 0001

0 · 8540 (0 · 8004–0 · 9112)

<0 · 0001

0 · 8743 (0 · 8222–0 · 9297)

Stable housinga

0 · 0466

0 · 7068 (0 · 4982–1 · 0027)

0 · 4938

0 · 8879 (0 · 6254–1 · 2606)

Drug abusea

0 · 0006

1 · 8976 (1 · 2787–2 · 8159)

0 · 3029

1 · 2341 (0 · 8096–1 · 8812)

Depressiona

<0 · 0001

1 · 8559 (1 · 3826–2 · 4912)

0 · 0413

1 · 3608

(1 · 019–1 · 8172)

    

Adherence (> = 95 %)a

<0 · 0001

0 · 3282 (0 · 2596–0 · 4148)

0 · 0049

0 · 6804 (0 · 5206–0 · 8892)

Antiretroviral Therapya

<0 · 0001

--

<0 · 0001

--

ARTb

0 · 0007

0 · 4858 (0 · 3197–0 · 7381)

<0 · 0001

0 · 3878 (0 · 2486–0 · 6048)

cART

0 · 0001

0 · 2488 (0 · 1711–0 · 3616)

<0 · 0001

0 · 2851 (0 · 1833–0 · 4434)

Alcohol use > = 7 drinks/week since last visita

<0 · 0001

2 · 4786 (1 · 5721–3 · 908)

0 · 0352

1 · 5921 (0 · 9956–2 · 546)

  1. Referents were less than high school for education, non-Hispanic caucasian for race, no private housing since last visit for housing, no reported drug use since last visit for drug abuse, <16 CESD for depression, adherence <95 % for adherence, and no antiretroviral drug use for therapy
  2. Abbreviations: ART antiretroviral therapy, CI confidence interval, CES-D Center for Epidemiologic studies of depression scale, cART highly active combination antiretroviral therapy, HIV human immunodeficiency virus, OR odds ratio
  3. atime-varying variable
  4. bSurvey measures differently from highly active antiretroviral therapy